Barry E. Gidal

5.3k citations
105 papers · 2.7k · 1 hit paper · h-index 30

Impact in

Papers in

Barry E. Gidal

99 papers receiving 2.6k citations

Barry E. Gidal's Hit Papers

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects 2018 · 349 citations
3490+2+5Years since publication100200300

Peers

Barry E. Gidal
Comparison fields: 5 of 120
  • Psychiatry and Mental health 1.3k
  • Pediatrics, Perinatology and Child Health 892
  • Pharmacology 507
  • Cellular and Molecular Neuroscience 486
  • Toxicology 41
Replace Peter M. Edelbroek with:
Peter M. Edelbroek Netherlands
Kenneth W. Sommerville United States
Cecilie Johannessen Landmark Norway
Manuela Contin Italy
Paul Rolan Australia
Angela K. Birnbaum United States
Frank Vajda Australia
G. Gatti Italy
Thomas R. Browne United States
John A. Messenheimer United States
Barry E. Gidal relative to Peter M. Edelbroek Netherlands Peter M. Edelbroek's profile →
Citations per field
00.5×4.2×
Peter M. Edelbroek · 1×
Citations per year

Countries citing papers authored by Barry E. Gidal

Since Specialization
Citations

This map shows the geographic impact of Barry E. Gidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry E. Gidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry E. Gidal more than expected).

Fields of papers citing papers by Barry E. Gidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry E. Gidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry E. Gidal. The network helps show where Barry E. Gidal may publish in the future.

Co-authors

The 25 scholars most cited alongside Barry E. Gidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barry E. Gidal Line = papers co-authored together Barry E. Gidal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Hit paper breakdown →
2018349
2
Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression.
1999152
3 2018141
4 2000116
5 201890
6 199888
7 200476
8 199876
9 200567
10 200364
11 200757
12 202057
13 200055
14
New and emerging treatment options for neuropathic pain.
200650
15 201848
16 201847
17 200647
18 199741
19 201540
20 200338

About Barry E. Gidal

Barry E. Gidal is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Cellular and Molecular Neuroscience, Pharmacology and Oncology, having authored 105 papers that have together received 2.7k indexed citations. Recurring topics across this work include Epilepsy research and treatment (64 papers), Pharmacological Effects and Toxicity Studies (38 papers), Neuroscience and Neuropharmacology Research (12 papers), Pharmaceutical studies and practices (9 papers), Drug Transport and Resistance Mechanisms (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Cannabis and Cannabinoid Research (4 papers) and Pharmaceutical Economics and Policy (4 papers). The work is most often cited by research in Psychiatry and Mental health (1.3k citations), Pediatrics, Perinatology and Child Health (892 citations), Pharmacology (507 citations), Cellular and Molecular Neuroscience (486 citations) and Toxicology (41 citations). Barry E. Gidal has collaborated with scholars based in United States, United Kingdom and Portugal. Frequent co-authors include Raj D. Sheth, Gilmour Morrison, Graham Blakey, Lesley Taylor, Bola Tayo, Bruce P. Hermann, Jacqueline A. French, Michael Seidenberg, Michael E. Pitterle and Austin Woodard. Their work appears in journals such as Epilepsy & Behavior, Epilepsia, Epiliepsy currents, Epilepsy Research and Annals of Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact